Metall Zug Ag Class B · SIX:METN

Metall Zug Ag Class B — H1 2026 Earnings Presentation

38 slides from Metall Zug Ag Class B's earnings presentation, Aug 24, 2026

  1. Slide 1: Investor & Media Presentation

    Investor & Media Presentation Metall Zug AG - Welcome August 24, 2026 Matthias Rey, CEO Urs Scherrer, CFO

  2. Slide 2: Content

    METALL ZUG GROUP Content 1. Group Financial Report 2. Business Units − Medical Devices − Technologycluster & Infrastructure − Investments & Corporate 3. Information for Investors Investor & Media Presentation - August 24, 2026 2

  3. Slide 3: What we have planned for 2026 and what we achieved in the first half-year

    METALL ZUG GROUP What we have planned for 2026 and what we achieved in the first half-year − Increase in sales and market share; focus on US and Europe − Focus on cost efficiency with implementation of further savings − Further conversion of innovation pipeline: Perimetry and software-related soluti

  4. Slide 4: Group Financial Report HY 1/2026

    Group Financial Report HY 1/2026 Metall Zug Group Investor & Media Presentation - August 24, 2026 Medical Devices Technologycluster & Investments & Corporate Infrastructure

  5. Slide 5: Income Statement

    METALL ZUG GROUP Income Statement Metall Zug Group HY 1/26 in % HY 1/25 in % Comment (in CHF million) Net sales 95.6 100.0 94.2 100.0 Cost of goods and services sold -63.0 -65.9 -63.2 -67.1 Gross profit 32.6 34.1 31.0 32.9 Marketing and sales expenses -12.5 -13.1 -13.9 -14.8 Research and development

  6. Slide 6: Strategic Investments

    METALL ZUG GROUP Strategic Investments Metall Zug Group V-ZUG Group Komax Group SteelcoBelimed Multi Energy Zug AG Total (in CHF million) HY 1/26 proportional net result 2.1 -1.2 -6.9 0.0 -6.0 Book value (proportional equity) 161.8 83.2 46.6 0.0 291.6 Market value (share price as of June 30) 86.7 55

  7. Slide 7: Net Sales HY 1/26

    Net Sales HY 1/26 by Business Unit by region 18% 12% (18%) (12%) 22% (22%) 37% (37%) 82% 29% (82%) (29%) Medical Devices Switzerland Investments & Corporate Europe w/o Switzerland Americas Technologycluster & Infrastructure (0%) Asia/Pacific/Others Investor & Media Presentation - August 24, 2026 7 (

  8. Slide 8: Net Sales Analysis

    METALL ZUG GROUP Net Sales Analysis 120.0 94.2 5.0 0.2 95.6 +1.4% 0.0 90.0 -3.8 in CHF million 60.0 30.0 0.0 Net sales FX Medical Devices Technologycluster & Investments & Net sales HY 1/25 Infrastructure Corporate HY 1/26 -4.1% +5.5% organic development Investor & Media Presentation - August 24, 20

  9. Slide 9: Operating Result (EBIT) Analysis

    METALL ZUG GROUP Operating Result (EBIT) Analysis 0.0 -2.0 3.2 -4.0 -0.9 -3.7 1.3 in CHF million -6.0 5.3 -8.0 -10.0 -12.0 -12.6 -14.0 EBIT Medical Devices Technologycluster & Investments & Corporate Investments & Corporate EBIT HY 1/25 Infrastructure (operational) (strategic investements) HY 1/26 I

  10. Slide 10: Balance Sheet

    METALL ZUG GROUP Balance Sheet Metall Zug Group 06/30/2026 in % 12/31/2025 in % Comment (in CHF million) Cash and cash equivalents / securities 16.5 2.4 16.2 2.4 Other current assets 131.8 18.9 118.7 17.8 Current assets 148.4 21.2 135.0 20.2 Tangible assets 204.6 29.3 192.7 28.9 Includes book values

  11. Slide 11: Cash Flow Statement

    METALL ZUG GROUP Cash Flow Statement Metall Zug Group HY 1/26 HY 1/25 Comment (in CHF million) Cash flow from operating activities 7.4 -5.4 Cash flow from investing activities -27.8 -27.1 - of which investments in tangible assets -24.8 -16.7 HY 1/26: includes purchase of shares in V-ZUG Holding AG o

  12. Slide 12: Business Units

    Business Units Metall Zug Group Investor & Media Presentation - August 24, 2026 Medical Devices Technologycluster & Investments & Corporate Infrastructure

  13. Slide 13: Medical Devices

    Medical Devices Medical Devices Investor & Media Presentation - August 24, 2026

  14. Slide 14: Highlights HY 1/26

    MEDICAL DEVICES Highlights HY 1/26 6.5% CHF 2.7m +20% Organic growth EBIT – return to profitability Unit sales of slit lamps Newly introduced Elara 900 hybrid digital slit lamp with solid demand Good sales performance of established slit lamp models, particularly in US market High-margin Simulation

  15. Slide 15: Key figures

    MEDICAL DEVICES Key figures HY 1/26 HY 1/25 (in CHF million) Net sales 78.2 77.1 Net sales development in % 1.5 -5.6 - of which foreign currency impact in % -5.0 -1.5 Organic net sales development in % 6.5 -4.1 Investments (expenses) in research and development -9.6 -12.6 Operating result (EBIT) 2.7

  16. Slide 16: Operating Result (EBIT) Analysis

    MEDICAL DEVICES Operating Result (EBIT) Analysis 4.0 3.0 2.7 1.6 2.0 3.0 in CHF million 1.0 0.0 -1.0 0.6 -2.0 0.4 -0.3 -3.0 -2.6 Revenue increase Marketing & Sales Admin and Other EBIT Margin decline Research & Development EBIT HY 1/25 HY 1/26 Investor & Media Presentation - August 24, 2026 16

  17. Slide 17: Net Sales

    MEDICAL DEVICES Net Sales Net sales by region Net sales by product area 5% (5%) 15% (15%) 13% (13%) 43% 35% 20% (41%) (35%) (20%) 45% 7% (6%) (45%) 17% (20%) Switzerland General Diagnostic Europe w/o Switzerland Specialities Americas Simulation Asia/Pacific/Others Chairs and Stands Accessories Inves

  18. Slide 18: US market

    MEDICAL DEVICES US market Relevance of US market in general: − US market generates approximately 40% of sales US tariff policy: − Impact of US tariffs partly passed on to customers through price adjustments in 2025 − Positive net effect on result of CHF 1.3 million from US tariff refunds following U

  19. Slide 19: Further growth in product portfolio

    MEDICAL DEVICES Further growth in product portfolio ▪ Launch of further innovative products is planned for the coming years Metis 900 ▪ Renewal and further digitalization of portfolio Refractor 900 ▪ New products will strengthen and expand Elara 900 market position METIS 3D-Heads-up Module ▪ In the

  20. Slide 20: Technologycluster & Infrastructure

    Technologycluster & Infrastructure Investor & Media Presentation - August 24, 2026

  21. Slide 21: Highlights HY 1/26

    TECHNOLOGYCLUSTER & INFRASTRUCTURE Highlights HY 1/26 CHF 2.1m SHL Südtor CreaTower I EBIT – increase of Move-in of SHL Medical Start of building CHF 1.3 million as first third-party construction industrial user ETH Learning Factory: start of preliminary project in August 2026 Start of design compet

  22. Slide 22: Key figures

    TECHNOLOGYCLUSTER & INFRASTRUCTURE Key figures HY 1/26 HY 1/25 (in CHF million) Net sales 0.0 0.0 Other operating income 7.1 6.5 Operating result (EBIT) 2.1 0.8 Employees (FTE) 28 30 CAPEX Total Rental income (in CHF million, cash flow view) (in CHF million) 23.0 14.7 5.2 4.6 HY 1/25 HY 1/25 HY 1/26

  23. Slide 23: Capex outlook 2026-2033

    TECHNOLOGYCLUSTER & INFRASTRUCTURE Capex outlook 2026-2033 (in CHF million; cash flow view) 2026 2027 2028 2029 2030 2031 2032 2033 CAPEX (net) Sales proceeds TOTAL CAPEX and down payments (gross) 62.2 62.8 8.2 48.7 49.7 42.8 45.3 2.6 0 42.0 10.1 39.0 44.6 19.4 22.7 17.6 54.6 47.1 Total accumulated

  24. Slide 24: Soil / building contamination remediation

    TECHNOLOGYCLUSTER & INFRASTRUCTURE Soil / building contamination remediation − Estimated cost for remediation of soil and building contamination at Tech Cluster Zug site for 2026-2045: CHF 30-40 million; already incurred cost until June 30, 2026: CHF 9.0 million − Provision recorded as of June 30, 2

  25. Slide 25: Rental income outlook 2026-2033

    TECHNOLOGYCLUSTER & INFRASTRUCTURE Rental income outlook 2026-2033 (in CHF million) 2026 2027 2028 2029 2030 2031 2032 2033 25.0 20.4 20.0 15.7 16.2 15.0 13.5 12.9 12.1 11.7 10.2 10.0 5.0 0.0 Investor & Media Presentation - August 24, 2026 25

  26. Slide 26: Site overview

    TECHNOLOGYCLUSTER & INFRASTRUCTURE Site overview Mobility Hub Zug Nord Adora: ETH Learning Factory refActory SHL-Südtor CreaTower I CreaTower II Pi Investor & Media Presentation - August 24, 2026 26

  27. Slide 27: SHL Südtor: New headquarters SHL Medical

    TECHNOLOGYCLUSTER & INFRASTRUCTURE SHL Südtor: New headquarters SHL Medical Project Description & Usage Production building for drug delivery systems and medical technology as well as office tower; in total 350-400 workplaces, 65% commercial, 35% office Key figures − Project time / completion 2021 t

  28. Slide 28: CreaTower I: VZ Depository Bank

    TECHNOLOGYCLUSTER & INFRASTRUCTURE CreaTower I: VZ Depository Bank Project Description & Usage Office high-rise with floor slabs made of non-reinforced precast concrete elements (RFS-system; 35% CO2 reduction), 90% office use, 10% gastronomy (incl. cafeteria) Key figures − Project time / completion

  29. Slide 29: Adora: ETH Learning Factory

    TECHNOLOGYCLUSTER & INFRASTRUCTURE Adora: ETH Learning Factory Overview − Presence of ETH Zurich: New innovative learning environment in the Tech Cluster Zug − Collaboration between students, apprentices and professionals − Challenges from Zug-based companies; interdisciplinary problem-solving skill

  30. Slide 30: Investments & Corporate

    Investments & Corporate Investor & Media Presentation - August 24, 2026

  31. Slide 31: Key figures

    INVESTMENTS & CORPORATE Key figures HY 1/26 HY 1/25 (in CHF million) Net sales 17.3 17.1 Net sales development in % 1.0 -47.7 Trading operating result -2.5 -5.6 in % of net sales -14.2 -32.7 Result from strategic investments (associated companies) -6.0 -5.1 Operating result (EBIT) -8.5 -10.8 Employe

  32. Slide 32: Key topics

    INVESTMENTS & CORPORATE Key topics − Net Sales CHF 17.3 million (previous year: CHF 17.1 million) − Growth driven primarily by rising sales figures in the thermal appliances and cleaning agents business areas − EBIT did not reach break-even point but significantly improved to prior year’s level − Im

  33. Slide 33: Key topics

    INVESTMENTS & CORPORATE Key topics Post-merger integration (PMI) – crucial main phase in 2026 − Legal entity consolidation expected to be completed by end of 2026 − IT transformation ongoing: SAP rollout in Cusano/Riese − New welding center in Cusano − Product phase outs and market launch of new pro

  34. Slide 34: We are happy to answer your questions

    Q A We are happy to answer your questions Investor & Media Presentation - August 24, 2026

  35. Slide 35: Information for Investors

    Information for Investors Metall Zug Group Investor & Media Presentation - August 24, 2026

  36. Slide 36: Financial calendar

    METALL ZUG GROUP Financial calendar March 22, 2027 Publication Annual Report 2026 / Earnings Conference April 30, 2027 General Meeting of the Shareholders 2027 August 18, 2027 Publication of Half-year Report 2027 Investor & Media Presentation - August 24, 2026 36

  37. Slide 37: Contact

    METALL ZUG GROUP Contact Urs Scherrer CFO Bettine Killmer Head of Corporate Communications & Investor Relations Metall Zug AG Industriestrasse 66 (postal address), Grienbachstrasse 11 (office address) 6302 Zug Switzerland investorrelations@metallzug.ch Phone: +41 58 768 60 50 Investor & Media Presen

  38. Slide 38: Disclaimer

    METALL ZUG GROUP Disclaimer Metall Zug AG has made great efforts to include accurate and up-to-date information in this document. However, we make no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided in this document and disclaim any

Metall Zug — H1 2026 Earnings Presentation on 6ix